Who we are
Medicines for Europe
Purpose and Objectives
OUR VALUES
STRUCTURE
OUR MEMBERS
BECOME A MEMBER
CODE OF CONDUCT
DISCLOSURE
JOB OPPORTUNITIES
Key topics
COVID-19
Access
INDUSTRIAL POLICY
REGULATORY AND LEGAL FRAMEWORK
FALSIFIED MEDICINES
ENVIRONMENT
ANTIMICROBIAL RESISTANCE
MEDICINE SHORTAGES
Publications
Factsheets
Infographics
Reports
Policy
Videos
Podcast
Newsroom
Press releases
In the news
Press kit
Contact us
Login
Generic medicines
Home
Who we are
Generic medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
Definition
THERAPEUTIC AREAS
GLOSSARY
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Related links
Contact us
Twitter
Biosimilar medicines
Home
Who we are
Biosimilar medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
DEFINITION
THERAPEUTIC AREAS
GLOSSARY
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
External resources
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Related links
Contact us
Twitter
Value added medicines
Home
Who we are
Value added medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
Environment of value added medicines in Europe
Definition
THERAPEUTIC AREAS
Q&A
What’s new
Environment of value added medicines in Europe
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
Value Added Medicines award 2019
QUOTES
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Contact us
Events
Newsroom
Filters:
Biosimilar medicines
x
press-releases
x
2022
x
News about
By type
In the news
Press releases
By year
2022
2021
2020
2019
2018
2017
2016
2015
2014
Twitter
Tweets
Videos
Photos
EMA/HMA share definitive EU-wide position on biosimilar medicines interchangeability
19 September 2022
Open
Medicines for Europe warns strongly against energy rationing for medicines production
20 July 2022
Open
The Supplementary Protection Certificate (SPC) manufacturing waiver becomes operational!
1 July 2022
Open
The off-patent medicines industry is a vital part of the solution for healthcare resilience
30 June 2022
Open
Smart reform of EU pharma and IP legislation key to boosting access to essential medicines
28 June 2022
Open
EPSCO (Health) Council – Open letter from Medicines for Europe Executive Committee to European Health Ministers and responsible European Commissioners on inflation impacting the supply of essential medicines
9 June 2022
Open
EU can do more for patients with smart use of biosimilar medicines
28 April 2022
Open
Central & Eastern European patients have inequitable access to medicines for life-threatening conditions
25 April 2022
Open
Subscribe to our newsletter
Tweet
Tweet
Tweet
LinkedIn
